Gossamer Bio Adds $276M in Second Biotech “Unicorn” IPO of 2019

Gossamer Bio, the San Diego-based biotech founded by former Receptos executives, has raised $276 million in its initial public offering, a total that puts it in a rare class among biotechs that have gone public in recent years.